StonvexLoading…
StonvexStonvexStonvexCore line items from INMB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $50.00K | $14.00K | $155.00K | $374.00K |
Operating Income | $-47.38M | $-42.63M | $-29.74M | $-25.95M |
Net Income | $-45.93M | $-42.08M | $-30.01M | $-27.30M |
EPS (Diluted) | $-1.86 | $-2.11 | $-1.67 | $-1.52 |
Total Assets | $32.35M | $39.56M | $57.00M | $81.80M |
Total Liabilities | $8.83M | $7.46M | $18.86M | $21.69M |
Cash & Equivalents | $24.75M | $20.92M | $35.85M | $52.15M |
Free Cash Flow OCF − CapEx | $-23.62M | Not available | Not available | Not available |
Shares Outstanding | 26.59M | 22.28M | 17.95M | 17.95M |